These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 26785154)
21. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Derry S; Sven-Rice A; Cole P; Tan T; Moore RA Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576 [TBL] [Abstract][Full Text] [Related]
22. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. Kerckhove N; Pereira B; Soriot-Thomas S; Alchaar H; Deleens R; Hieng VS; Serra E; Lanteri-Minet M; Arcagni P; Picard P; Lefebvre-Kuntz D; Maindet C; Mick G; Balp L; Lucas C; Creach C; Letellier M; Martinez V; Navez M; Delbrouck D; Kuhn E; Piquet E; Bozzolo E; Brosse C; Lietar B; Marcaillou F; Hamdani A; Leroux-Bromberg N; Perier Y; Vergne-Salle P; Gov C; Delage N; Gillet D; Romettino S; Richard D; Mallet C; Bernard L; Lambert C; Dubray C; Duale C; Eschalier A Eur J Pain; 2018 Aug; 22(7):1321-1330. PubMed ID: 29577519 [TBL] [Abstract][Full Text] [Related]
24. Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist. Murgasova R; Carreras ET; Suetterlin-Hachmann M; da Silva Torrao LR; Kittelmann M; Alexandra V; Fredenhagen A Biopharm Drug Dispos; 2020 Apr; 41(4-5):166-183. PubMed ID: 32190910 [TBL] [Abstract][Full Text] [Related]
25. New investigational drugs for the treatment of neuropathic pain. Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842 [TBL] [Abstract][Full Text] [Related]
26. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. de Leeuw TG; Mangiarini L; Lundin R; Kaguelidou F; van der Zanden T; Pasqua OD; Tibboel D; Ceci A; de Wildt SN; Trials; 2019 Jan; 20(1):49. PubMed ID: 30646965 [TBL] [Abstract][Full Text] [Related]
27. Elucidation of pathophysiology and treatment of neuropathic pain. Vranken JH Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930 [TBL] [Abstract][Full Text] [Related]
28. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions. Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Watson CP; Babul N Neurology; 1998 Jun; 50(6):1837-41. PubMed ID: 9633737 [TBL] [Abstract][Full Text] [Related]
31. [Botulinum toxin and painful peripheral neuropathies: what should be expected?]. Ranoux D Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720 [TBL] [Abstract][Full Text] [Related]
32. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Silver M; Blum D; Grainger J; Hammer AE; Quessy S J Pain Symptom Manage; 2007 Oct; 34(4):446-54. PubMed ID: 17662571 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial. Kerckhove N; Mallet C; Pereira B; Chenaf C; Duale C; Dubray C; Eschalier A BMJ Open; 2016 Dec; 6(12):e013530. PubMed ID: 27986742 [TBL] [Abstract][Full Text] [Related]
34. The evidence for pharmacological treatment of neuropathic pain. Finnerup NB; Sindrup SH; Jensen TS Pain; 2010 Sep; 150(3):573-581. PubMed ID: 20705215 [TBL] [Abstract][Full Text] [Related]
35. Attenuation of the Infiltration of Angiotensin II Expressing CD3 Khan N; Muralidharan A; Smith MT Front Mol Neurosci; 2017; 10():389. PubMed ID: 29200998 [TBL] [Abstract][Full Text] [Related]